A case report on the association between QTc prolongation and remdesivir therapy in a critically ill patient

Remdesivir is a direct-acting inhibitor of SARS-CoV-2 RNA-dependent RNA polymerase that is used to treat severe COVID-19 infections. We report a patient with severe COVID-19 pneumonia who experienced palpitations and syncope two days after starting remdesivir therapy. The QTc interval was prolonged...

Descripción completa

Detalles Bibliográficos
Autores principales: Harbi, Shmeylan Al, AlFaifi, Mashael, Al-Dorzi, Hasan M., Aljuhani, Ohoud, Alenazi, Abeer A., Alalawi, Mai, Sulaiman, Khalid Al
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284529/
https://www.ncbi.nlm.nih.gov/pubmed/35855472
http://dx.doi.org/10.1016/j.idcr.2022.e01572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284529/
https://www.ncbi.nlm.nih.gov/pubmed/35855472
http://dx.doi.org/10.1016/j.idcr.2022.e01572

Ejemplares similares